Creo Medical Group PLC

Equities

CREO

GB00BZ1BLL44

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. 11:35:23 2024-04-24 am EDT 5-day change 1st Jan Change
35.1 GBX +1.01% Intraday chart for Creo Medical Group PLC +1.74% -23.70%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
ActiveOps sales up; Sancus turnover jumps AN
EARNINGS AND TRADING: Dar Global celebrates "outstanding" year AN
Creo Medical Group plc Announces Microwave Lung Ablation Update CI
Creo Medical makes "considerable strides" toward 2025 break-even goal AN
Creo Medical partners with Khalifa University in Abu Dhabi AN
Creo Medical Group plc Announces Strategic Collaboration with Khalifa University of Science and Technology CI
Creo unveils product in APAC; Unilever hires director AN
Creo Medical Group plc Announces Continued Progress on the Phased Market Release of Its Latest Device, Speedboat® UltraSlim CI
Creo Medical's Speedboat UlstraSlim device used in Latin America AN
Creo Medical's SpeedBoat UltraSlim successfully used in US AN
Creo Medical Group plc Announces First Use of Speedboat UltraSlim in the USA CI
Good Energy says ZapMap expands into mainland Europe AN
Creo Medical Group PLC Announces the Initiation of Its Commercial Launch of Speedboat Ultraslim CI
Creo Medical Wins US FDA Nod for Medical Endoscopy Device MT
Creo Medical Group plc Receives 510(K) Clearance from the Us Food & Drug Administration for Its Speedboat Ultraslim Device CI
Creo Medical says EU launch of SpeedBoat UltraSlim device accelerated AN
Creo Medical Expedites Medical Endoscopy Device Launch in Europe MT
Creo Medical Group plc Announces EU Launch Accelerated by 18 Months Eu Regulatory Pathway for Launch Early 2024 CI
Creo Medical Group PLC Announces Change of Nominated Adviser and Joint Broker from Cavendish Securities plc to Cavendish Capital Markets Limited CI
FTSE 100 Closes Tuesday Up 0.41% as Oil-Price Rises Benefit the Index DJ
Creo Medical hails Speedboat Inject device as interim loss narrows AN
FTSE 100 Rises, Led by AB Foods; Smurfit Kappa Slides DJ
Earnings Flash (CREO.L) CREO MEDICAL GROUP Reports H1 Revenue GBP15.7M MT
Earnings Flash (CREO.L) CREO MEDICAL GROUP Posts H1 Loss GBP-0.04 MT
Creo Medical Group PLC Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Chart Creo Medical Group PLC
More charts
Creo Medical Group plc is a medical device company. The Company is focused on the development and commercialization of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. It is engaged in research, development and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. The Company has developed the CROMA powered by Kamaptive full-spectrum adaptive technology, which provides optimized surgical capability and patient outcomes. The Kamaptive is a seamless, intuitive integration of multi-modal energy sources. Its CROMA delivers bipolar radiofrequency (RF) energy for precise localized cutting and focused high frequency microwave (MW) energy for controlled coagulation and ablation via a single accessory port. This technology, combined with its range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.351 GBP
Average target price
0.995 GBP
Spread / Average Target
+183.48%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CREO Stock
  4. News Creo Medical Group PLC
  5. Creo Medical Inks Heads of Terms Deals with Partners in Related Markets